메뉴 건너뛰기




Volumn 17, Issue 2, 2004, Pages 84-89

Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: An open parallel long-term study

Author keywords

CSII; Glargine; MDI therapy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

EID: 2942560655     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (34)

References (20)
  • 1
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
    • (1993) N. Engl. J. Med. , vol.329 , pp. 977-986
  • 2
    • 0033982901 scopus 로고    scopus 로고
    • Standards of medical care for patients with diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 23 (Suppl. 1): S32-S42, 2000.
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL. 1
  • 3
    • 0036700805 scopus 로고    scopus 로고
    • Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients
    • Lepore G., Bruttomesso D., Nosari I., Tiengo A., Trevisan R.: Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Diab. Nutr. Metab. 15: 232-239, 2002.
    • (2002) Diab. Nutr. Metab. , vol.15 , pp. 232-239
    • Lepore, G.1    Bruttomesso, D.2    Nosari, I.3    Tiengo, A.4    Trevisan, R.5
  • 4
    • 0037160919 scopus 로고    scopus 로고
    • Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials
    • Pickup J., Mattock M., Kerry S.: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br. Med. J. 324: 705-710, 2002.
    • (2002) Br. Med. J. , vol.324 , pp. 705-710
    • Pickup, J.1    Mattock, M.2    Kerry, S.3
  • 5
    • 0033661254 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodymanics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and continuous subcutaneous infusion of insulin lispro
    • Lepore M., Pampanelli S., Fanelli C., Porcellati F., Bartocci L., Di Vincenzo A., Cordoni C., Costa E., Brunetti P., Bolli G.B.: Pharmacokinetics and pharmacodymanics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49: 2142-2148, 2000.
    • (2000) Diabetes , vol.49 , pp. 2142-2148
    • Lepore, M.1    Pampanelli, S.2    Fanelli, C.3    Porcellati, F.4    Bartocci, L.5    Di Vincenzo, A.6    Cordoni, C.7    Costa, E.8    Brunetti, P.9    Bolli, G.B.10
  • 6
    • 0034033028 scopus 로고    scopus 로고
    • Less hypoglycaemia with insulin glargine in intensive insulin therapy for type 1 diabetes
    • U.S. Study Group of Insulin Glargine in Type 1 Diabetes
    • Ratner R.E., Hirsch I.B., Neifing J.L., Garg S.K., Mecca T.E., Wilson C.A.: Less hypoglycaemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 23: 639-643, 2000.
    • (2000) Diabetes Care , vol.23 , pp. 639-643
    • Ratner, R.E.1    Hirsch, I.B.2    Neifing, J.L.3    Garg, S.K.4    Mecca, T.E.5    Wilson, C.A.6
  • 7
    • 0041488883 scopus 로고    scopus 로고
    • Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment
    • Lepore G., Dodesini A.R., Nosari I., Trevisan R.: Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 26: 1321-1322, 2003.
    • (2003) Diabetes Care , vol.26 , pp. 1321-1322
    • Lepore, G.1    Dodesini, A.R.2    Nosari, I.3    Trevisan, R.4
  • 9
    • 2942589458 scopus 로고    scopus 로고
    • A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes
    • Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract 1900-PO)
    • Mathur R., Harmel A.L.P.: A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract 1900-PO).
    • (2003)
    • Mathur, R.1    Harmel, A.L.P.2
  • 10
    • 2942615682 scopus 로고    scopus 로고
    • Short-term comparison between glargine as basal insulin and CSII in CSII-treated type 1 diabetic patients switching to MDI: The pump holiday study
    • Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract LB-13)
    • Torlone E., Pampanelli S., Porcellati F.: Short-term comparison between glargine as basal insulin and CSII in CSII-treated type 1 diabetic patients switching to MDI: the pump holiday study. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract LB-13).
    • (2003)
    • Torlone, E.1    Pampanelli, S.2    Porcellati, F.3
  • 11
    • 3042780815 scopus 로고    scopus 로고
    • Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine
    • (Abstract)
    • Bode B., Hirsch I., Hu P., Santiago O.: Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine. Diabetologia 46 (Suppl. 213): A270, 2003 (Abstract).
    • (2003) Diabetologia , vol.46 , Issue.SUPPL. 213
    • Bode, B.1    Hirsch, I.2    Hu, P.3    Santiago, O.4
  • 12
    • 2942587682 scopus 로고    scopus 로고
    • Randomized, prospective trial of CSII with glargine in children: A preliminary report
    • Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, New Orleans (Abstract 192-OR)
    • Boland E., Weinzimer S., Ahern J.A., Steffen A., Tamborlane W.: Randomized, prospective trial of CSII with glargine in children: a preliminary report. Program and abstracts of the 63rd Scientific Sessions of the American Diabetes Association, June 13-17, 2003, New Orleans (Abstract 192-OR).
    • (2003)
    • Boland, E.1    Weinzimer, S.2    Ahern, J.A.3    Steffen, A.4    Tamborlane, W.5
  • 15
    • 0029927589 scopus 로고    scopus 로고
    • Insulin pump therapy: Acceptable alternative to injection therapy
    • Marcus A.O., Fernandez M.P.: Insulin pump therapy: acceptable alternative to injection therapy. Postgrad. Med. 99: 125-143, 1996.
    • (1996) Postgrad. Med. , vol.99 , pp. 125-143
    • Marcus, A.O.1    Fernandez, M.P.2
  • 16
    • 0029912364 scopus 로고    scopus 로고
    • Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
    • Bode B.W., Steed R.D., Davidson P.C.: Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19: 324-327, 1996.
    • (1996) Diabetes Care , vol.19 , pp. 324-327
    • Bode, B.W.1    Steed, R.D.2    Davidson, P.C.3
  • 17
    • 0032710719 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes
    • Boland E.A., Grey M., Osterle A., Fredrickson L., Tamborlane W.: Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22: 1799-1784, 1999.
    • (1999) Diabetes Care , vol.22 , pp. 1784-1799
    • Boland, E.A.1    Grey, M.2    Osterle, A.3    Fredrickson, L.4    Tamborlane, W.5
  • 18
    • 0023791423 scopus 로고
    • Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial
    • DCCT Research Group
    • DCCT Research Group: Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11: 567-573, 1988.
    • (1988) Diabetes Care , vol.11 , pp. 567-573
  • 20
    • 0036426805 scopus 로고    scopus 로고
    • Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study
    • Orchard T.J., Chang Y.F., Ferrell R.E., Petro N., Ellis D.E.: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int. 62: 963-970, 2002
    • (2002) Kidney Int. , vol.62 , pp. 963-970
    • Orchard, T.J.1    Chang, Y.F.2    Ferrell, R.E.3    Petro, N.4    Ellis, D.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.